Enzon Pharmaceuticals Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
18,150.00
28,795.00
21,637.00
1,126.00
5,445.00
5,849
Depreciation, Depletion & Amortization
232.00
-
-
-
-
-
Other Funds
316.00
30.00
6.00
-
-
-
Funds from Operations
17,231.00
28,734.00
10,526.00
6,623.00
8,807.00
5,849
Changes in Working Capital
3,226.00
3,604.00
4,152.00
4,024.00
2,336.00
6,827
Net Operating Cash Flow
14,005.00
32,338.00
14,678.00
2,599.00
6,471.00
978
Sale of Fixed Assets & Businesses
2,234.00
151.00
-
-
-
Purchase/Sale of Investments
118,894.00
-
-
-
-
Net Investing Cash Flow
121,128.00
151.00
-
-
-
Cash Dividends Paid - Total
89,808.00
4,417.00
37,562.00
6,632.00
6,632.00
Issuance/Reduction of Debt, Net
115,849.00
-
-
-
-
Net Financing Cash Flow
205,961.00
4,447.00
37,568.00
6,632.00
6,632.00
Net Change in Cash
70,828.00
28,042.00
22,890.00
4,033.00
161.00
Free Cash Flow
14,005.00
-
14,678.00
2,599.00
6,471.00
Deferred Taxes & Investment Tax Credit
-
-
11,111.00
7,749.00
3,362.00
-
Change in Capital Stock
12.00
-
-
-
-
About Enzon Pharmaceuticals
View Profile
